Previous studies using TSPO PET imaging have shown increased regional ligand-binding in patients with AD [20–23], mild cognitive impairment [4, 24, 25], and some also in Aβ-positive compared with Aβ-negative controls [7, 26]. The gene discussed is TSPO; the disease is Alzheimer disease.